Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Infographic – US Biotech Investments Stay Strong

Chart: biotech venture investments

The first half half of 2022 shows venture investments in U.S. biotechnology start-ups cooled from the blistering pace of last year, but biotech remains a robust sector. . . . → Read More: Infographic – US Biotech Investments Stay Strong

Precision Protein Design Start-Up Gains $40M in Early Funds

Chemical atom model

A start-up company designing and testing precise proteins within live animals to speed creation of new therapeutics is raising $40 million in its first venture round. . . . → Read More: Precision Protein Design Start-Up Gains $40M in Early Funds

Biotechs Explore Gut-Brain Axis for Mental Health

Microbiome graphic

Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders. . . . → Read More: Biotechs Explore Gut-Brain Axis for Mental Health

Infographic – Q2 Venture Funds Decline Continues

Chart: Venture funding Q1 2022

Venture capital funds for North American technology start-ups continued their fall in the second quarter, with later-stage rounds showing the greatest drop. . . . → Read More: Infographic – Q2 Venture Funds Decline Continues

Precision Microbial Resistance Joint Venture Formed

MRSA bacteria

Biotech, pharma, and diagnostics companies are forming a new business to design precision diagnostics and treatments for drug-resistant microbes. . . . → Read More: Precision Microbial Resistance Joint Venture Formed

Smell Detection Tech Company Raises $4M in Seed Funds

Dog's nose

A start-up biotechnology company creating a system that translates an animal’s sense of smell into electronic signals is raising $4 million in seed equity funds. . . . → Read More: Smell Detection Tech Company Raises $4M in Seed Funds

Cancer Nutrition Therapy Biotech Raises $47M in Early Funds

Faeth app screen shots

A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round. . . . → Read More: Cancer Nutrition Therapy Biotech Raises $47M in Early Funds

Infographic – Q1 Mental Health Tech Funds Drop

Mental health tech venture funds

After a year of nearly constant gains in 2021, venture investments in digital mental health companies took a sharp drop in the first quarter of 2022. . . . → Read More: Infographic – Q1 Mental Health Tech Funds Drop

Gene Therapy Start-Up Gains $38M in Early Funds

Gene therapy graphic

A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds. . . . → Read More: Gene Therapy Start-Up Gains $38M in Early Funds

Life Science Investors Raise $1.1B for New Fund

Investor screen

A venture capital company specializing in health and life sciences start-up enterprises is raising $1.1 billion for a new investment fund. . . . → Read More: Life Science Investors Raise $1.1B for New Fund